A Korean phase 3 trial found cutting radiation sessions from 33 to 26 after prostate cancer surgery gave similar four-year ...
AI-based research identifies ZNF268 as a potential marker of prostate cancer progression, raising hopes for more accurate ...
A new study shows that an interpretable AI model fusing 18F-PSMA-1007 PET/CT and multiparametric MRI can predict prostate ...
Overcoming a lifelong fear of needles, I underwent prostate cancer screening. I urge men to prioritize preventive health.
An urologist explains why a PSA test is just the first step in the screening process for prostate cancer screenings. Learn what contributes to your PSA results.
A urologist explains how prostate treatments differ in relief, side effects, recovery, and how well they fit individual needs.
Last time, I wrote that the chemotherapy drug 'docetaxel,' which was scheduled for a total of six sessions, was discontinued ...
Men newly diagnosed with prostate cancer face a range of treatment options, from robotic surgery and focal therapy to ...
Prostate cancer is the second most commonly diagnosed cancer among men worldwide, with an estimated 1.55 million new cases in ...
Prostate cancer is a silent disease. There are no outward signs to signal that something is wrong and there’s no guaranteed ...
The phase 2/3 NRG GU002 trial (NCT03070886) evaluated whether adding 6 cycles of docetaxel after radiation and androgen ...
CHAPS, the leading prostate screening charity, is holding a unique workshop aiming to tackle the conflicting messages men are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results